6Newman M J, Frimpong E, Donkor ES, et al. Resistance to an- timicrobial drugs in Ghana [ J]. Infec Drug Resist,2011,4 : 215 -220.
7Ozdemir H, Ciftci E, Karbuz A, et al. Successful treatment of multidrug - resistant Escherichia coli bacteremia with tigecy- cline in an acute myeloid leukemia child [ J ]. Turk J Pedi- atr,2012,54 ( 1 ) :59 - 60.
8Fong J J, Rose L, Radigan EA. Clinical outcomes with ertap- enem as a first - line treatment option of infections caused by extended - spectrum 13 - lactamase producing gram - nega- tive bacteria [ J ]. Ann Pharmacother, 2012,46 ( 3 ) : 347 - 352.
5Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; nineteeth informational supplement. Wayne: Clinical and Laboratory Standards Institute. 2009.
6Bush K. Alarming b - lactamase - mediated resistance in multidrug - resistant Enterobacteriaceae[ J]. Curr Opinion Microb, 2010 ; 13 : 558 - 564.
7Pfeifer Y, Cullik A, Witte W. Resistance to cephalosporins and carbapenems in Gram- negative bacterial pathogens[J].Int J Med Microbiol, 2010; 300:17-379.
8Yang Q, Wang H, Sun H, et al. Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital - based surveillance studies in China[ J]. Antimicrob Agents Chemother, 2010 ; 54:573 - 577.
9Wu Q, Liu Q, Han L, et al. Plasmid - mediated carbapenem hydrolyzing enzyme KPC -2 and Arm A 16S rRNA methylase conferring high - level aminoglycoside resistance in carbapenem - resistant Enterobacter cloacae in China[ J ]. Diag Microbiol Infect Dis, 2010 ; 66:326 - 328.
10Jacoby GA. Amp C b - lactamases[ J ]. Clin Microbiol Rev, 2009 ; 22 : 161 - 152.
